Japan, Feb. 27 -- HUMMINGBIRD BIOSCIENCE PTE LTD has got intellectual property rights for 'HER3 ANTIGEN-BINDING MOLECULES.' Other related details are as follows:
Application Number: JP,2024-141689
Category (FI): C12N5/10,G01N33/57545,G01N33/5755,G01N33/57555,A61K31/7088,G01N33/5754,G01N33/57535,G01N33/5753,G01N33/57525,G01N33/5752,G01N33/57515,G01N33/5751,G01N33/57505,G01N33/575@A,G01N33/574@A,A61P35/00,A61K35/12,A61K48/00,A61K39/395@T,C12P21/08,C07K16/28,C07K16/46,C12N15/13,C12N15/62@Z,C12N15/63@Z,C12N1/15,C12N1/19,C12N1/21
Stage: PROBLEM TO BE SOLVED: To provide HER3 antigen-binding molecules, nucleic acids and expression vectors encoding the HER3 antigen-binding molecules, compositions comprising the HER3 antigen-binding molecules, and methods using the HER3 antigen-binding molecules.SOLUTION: In a first aspect, the present invention provides an antigen-binding molecule, optionally isolated, which is capable of binding to HER3 in extracellular region subdomain II. In some embodiments, the antigen-binding molecule inhibits interaction between HER3 and an interaction partner for HER3. In some embodiments, the antigen-binding molecule is capable of binding to a polypeptide comprising or consisting of a specific amino acid sequence. The present invention also provides an antigen-binding molecule, optionally isolated, comprising (i) an antigen-binding molecule according to the present invention, and (ii) an antigen-binding molecule capable of binding to an antigen other than HER3.SELECTED DRAWING: Figure 1A (Grant)
Filing Date: Aug. 23, 2024
Publication Date: Nov. 26, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
